Skip to main content
SpringerLink
Log in

The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Background

Low serum 25-hydroxyvitamin D [25(OH)D] levels have been associated with higher risk of many diseases that affect mortality, including cardiovascular disease (CVD) and cancer. The inverse association between serum 25(OH)D and mortality may be modified by excess circulating vitamin A, due to interactions of vitamin A at the level of the vitamin D nuclear receptor. In this prospective cohort study, we investigated whether the association of 25(OH)D with all-cause, cancer, and CVD mortality was modified by circulating vitamin A or preformed vitamin A intake from supplements.

Methods

We analyzed 15,998 adults in the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994. Mortality data for all-cause (n = 3890), cancer (n = 844), and CVD mortality (n = 1715) were assessed through December 2006. Serum 25(OH)D was measured using a radioimmunoassay kit, vitamin A biomarkers were measured by HPLC, and information on supplement use was obtained by self-report. Multivariable hazard ratios (HRs) and corresponding 95 % confidence intervals (CI) were estimated by proportional hazards regression.

Results

Serum 25(OH)D was significantly inversely associated with all-cause mortality (HR 0.93, 95 % CI 0.89, 0.97, per 10 ng/mL increase) and also with CVD mortality and mortality due to non-cancer/non-cardiovascular causes, but not with cancer mortality. The observed inverse associations remained statistically significant only among participants with serum retinyl esters <7.0 μg/dL. High intake (>5000 IU/day) of preformed vitamin A from supplements attenuated the inverse association of 25(OH)D with overall mortality. The observed interactions were not statistically significant.

Conclusions

25(OH)D was inversely associated with overall mortality, CVD mortality, and mortality due to non-cancer/non-CVD causes, but not with cancer mortality. A possible interaction between vitamin A exposure and 25(OH)D concentration appears to be associated with an attenuation of the inverse association between risk of death and quartile of 25(OH)D concentration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Pilz S, Tomaschitz A, Marz W, Drechsler C, Ritz E, Zittermann A, Cavalier E, Pieber TR, Lappe JM, Grant WB, Holick MF, Dekker JM (2011) Vitamin D, cardiovascular disease and mortality. Clin Endocrinol 75(5):575–584. doi:10.1111/J.1365-2265.2011.04147.X

    Article  CAS  Google Scholar 

  2. Arnson Y, Amital H, Shoenfeld Y (2007) Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 66(9):1137–1142. doi:10.1136/ard.2007.069831

    Article  CAS  Google Scholar 

  3. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, Bischoff-Ferrari HA, Cavalier E, Ebeling PR, Fardellone P, Gandini S, Gruson D, Guerin AP, Heickendorff L, Hollis BW, Ish-Shalom S, Jean G, von Landenberg P, Largura A, Olsson T, Pierrot-Deseilligny C, Pilz S, Tincani A, Valcour A, Zittermann A (2010) Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: recommendations for clinical practice. Autoimmun Rev 9(11):709–715. doi:10.1016/j.autrev.2010.06.009

    Article  CAS  Google Scholar 

  4. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91(5):1255–1260. doi:10.3945/ajcn.2009.29094

    Article  CAS  Google Scholar 

  5. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML (2010) Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 5(6):e11088. doi:10.1371/journal.pone.0011088

    Article  Google Scholar 

  6. Feldman D, Krishnan AV, Swami S, Giovannucci E, Feldman BJ (2014) The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. doi:10.1038/nrc3691

    Google Scholar 

  7. Welsh J (2012) Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys 523(1):107–114. doi:10.1016/J.Abb.2011.10.019

    Article  CAS  Google Scholar 

  8. Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S (2012) Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr 95(1):91–100. doi:10.3945/ajcn.111.014779

    Article  CAS  Google Scholar 

  9. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. doi:10.1056/NEJMra070553

    Article  CAS  Google Scholar 

  10. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH (2014) Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ 348:g1903. doi:10.1136/bmj.g1903

    Article  Google Scholar 

  11. Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5(7):2502–2521. doi:10.3390/Nu5072502

    Article  CAS  Google Scholar 

  12. Hewison M (2012) An update on vitamin D and human immunity. Clin Endocrinol (Oxf) 76(3):315–325. doi:10.1111/j.1365-2265.2011.04261.x

    Article  CAS  Google Scholar 

  13. Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94(1):26–34. doi:10.1210/jc.2008-1454

    Article  CAS  Google Scholar 

  14. Lee S, Clark SA, Gill RK, Christakos S (1994) 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Endocrinology 134(4):1602–1610. doi:10.1210/endo.134.4.8137721

    CAS  Google Scholar 

  15. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP (2002) 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin–angiotensin system. J Clin Investig 110(2):229–238. doi:10.1172/JCI15219

    Article  CAS  Google Scholar 

  16. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J, Group IOFCoSANW (2009) Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20(11):1807–1820. doi:10.1007/s00198-009-0954-6

    Article  CAS  Google Scholar 

  17. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK (1997) The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol 154(Suppl):S57–S73

    CAS  Google Scholar 

  18. Thompson PD, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR (1998) Heterodimeric DNA binding by the vitamin D receptor and retinoid X receptors is enhanced by 1,25-dihydroxyvitamin D3 and inhibited by 9-cis-retinoic acid. Evidence for allosteric receptor interactions. J Biol Chem 273(14):8483–8491

    Article  CAS  Google Scholar 

  19. Cheng TY, Neuhouser ML (2012) Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient–nutrient interaction. Cancer Causes Control 23(9):1557–1565. doi:10.1007/s10552-012-0033-8

    Article  Google Scholar 

  20. Cheng TY, Lacroix AZ, Beresford SA, Goodman GE, Thornquist MD, Zheng Y, Chlebowski RT, Ho GY, Neuhouser ML (2013) Vitamin D intake and lung cancer risk in the women’s health initiative. Am J Clin Nutr 98(4):1002–1011. doi:10.3945/ajcn.112.055905

    Article  CAS  Google Scholar 

  21. Oh K, Willett WC, Wu K, Fuchs CS, Giovannucci EL (2007) Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol 165(10):1178–1186. doi:10.1093/aje/kwm026

    Article  Google Scholar 

  22. Bao Y, Ng K, Wolpin BM, Michaud DS, Giovannucci E, Fuchs CS (2010) Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer 102(9):1422–1427. doi:10.1038/sj.bjc.6605658

    Article  CAS  Google Scholar 

  23. National Center for Health Statistics (1994) Plan and operation of the third National Health and Nutrition Examination Survey, 1988–94. vol 32. Natl Ctr for Health Statistics

  24. Dukas L, Platz EA, Colditz GA, Willet WC, Giovannucci EL (2000) Bowel movement, use of laxatives and risk of colorectal adenomatous polyps among women (United States). Cancer Causes Control 11(10):907–914

    Article  CAS  Google Scholar 

  25. European Commission, Scientific Committee on Food (2002) Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Preformed Vitamin A (retinol and retinyl esters)

  26. Blomhoff R, Beckman-Sundh U, Brot C, Solvoll C, Steingrimsdóttir L, Carlsen MH (2003) Health risks related to high intake of preformed retinol (vitamin A) in the Nordic countries. Nordic Council of Ministers

  27. Ballew C, Galuska D, Gillespie C (2001) High serum retinyl esters are not associated with reduced bone mineral density in the third national health and nutrition examination survey, 1988–1994. J Bone Miner Res 16(12):2306–2312. doi:10.1359/jbmr.2001.16.12.2306

    Article  CAS  Google Scholar 

  28. Willett W (2013) Nutritional epidemiology, vol 40. Oxford University Press, Oxford

    Google Scholar 

  29. Krasinski SD, Russell RM, Otradovec CL, Sadowski JA, Hartz SC, Jacob RA, McGandy RB (1989) Relationship of vitamin A and vitamin E intake to fasting plasma retinol, retinol-binding protein, retinyl esters, carotene, alpha-tocopherol, and cholesterol among elderly people and young adults: increased plasma retinyl esters among vitamin A-supplement users. Am J Clin Nutr 49(1):112–120

    CAS  Google Scholar 

  30. Smith FR, Goodman DS (1976) Vitamin A transport in human vitamin A toxicity. N Engl J Med 294(15):805–808. doi:10.1056/NEJM197604082941503

    Article  CAS  Google Scholar 

  31. Schottker B, Jorde R, Peasey A, Thorand B, Jansen EH, Groot L, Streppel M, Gardiner J, Ordonez-Mena JM, Perna L, Wilsgaard T, Rathmann W, Feskens E, Kampman E, Siganos G, Njolstad I, Mathiesen EB, Kubinova R, Pajak A, Topor-Madry R, Tamosiunas A, Hughes M, Kee F, Bobak M, Trichopoulou A, Boffetta P, Brenner H, Consortium on H, Ageing: Network of Cohorts in E, the United S (2014) Vitamin D and mortality: meta-analysis of individual participant data from a large consortium of cohort studies from Europe and the United States. BMJ 348:g3656. doi:10.1136/bmj.g3656

    Article  Google Scholar 

  32. Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C (2014) Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 1:CD007470. doi:10.1002/14651858.CD007470.pub3

    Google Scholar 

  33. Rush L, McCartney G, Walsh D, Mackay D (2013) Vitamin D and subsequent all-age and premature mortality: a systematic review. BMC Public Health 13(1):679. doi:10.1186/1471-2458-13-679

    Article  Google Scholar 

  34. Schottker B, Ball D, Gellert C, Brenner H (2013) Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 12(2):708–718. doi:10.1016/j.arr.2012.02.004

    Article  Google Scholar 

  35. Wang L, Song Y, Manson JE, Pilz S, Marz W, Michaelsson K, Lundqvist A, Jassal SK, Barrett-Connor E, Zhang C, Eaton CB, May HT, Anderson JL, Sesso HD (2012) Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes 5(6):819–829. doi:10.1161/CIRCOUTCOMES.112.967604

    Article  CAS  Google Scholar 

  36. Pilz S, Tomaschitz A, Obermayer-Pietsch B, Dobnig H, Pieber TR (2009) Epidemiology of vitamin D insufficiency and cancer mortality. Anticancer Res 29(9):3699–3704

    Google Scholar 

  37. Bikle DD (2014) Vitamin D and cancer: the promise not yet fulfilled. Endocrine 46(1):29–38. doi:10.1007/s12020-013-0146-1

    Article  CAS  Google Scholar 

  38. Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, Berglund L, Arnlov J, Hellman P, Blomhoff R, Wolk A, Garmo H, Holmberg L, Melhus H (2010) Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 92(4):841–848. doi:10.3945/ajcn.2010.29749

    Article  CAS  Google Scholar 

  39. Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H (2010) Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121(2):469–477. doi:10.1007/s10549-009-0593-9

    Article  CAS  Google Scholar 

  40. Gandini S, Boniol M, Haukka J, Byrnes G, Cox B, Sneyd MJ, Mullie P, Autier P (2011) Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 128(6):1414–1424. doi:10.1002/ijc.25439

    Article  CAS  Google Scholar 

  41. Gilbert R, Martin RM, Beynon R, Harris R, Savovic J, Zuccolo L, Bekkering GE, Fraser WD, Sterne JA, Metcalfe C (2011) Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 22(3):319–340. doi:10.1007/s10552-010-9706-3

    Article  Google Scholar 

  42. Ma Y, Zhang P, Wang F, Yang J, Liu Z, Qin H (2011) Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29(28):3775–3782. doi:10.1200/JCO.2011.35.7566

    Article  CAS  Google Scholar 

  43. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H (2011) Meta-analysis: serum vitamin D and colorectal adenoma risk. Prev Med 53(1–2):10–16. doi:10.1016/j.ypmed.2011.05.013

    Article  CAS  Google Scholar 

  44. Yin L, Ordonez-Mena JM, Chen T, Schottker B, Arndt V, Brenner H (2013) Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med 57(6):753–764. doi:10.1016/j.ypmed.2013.08.026

    Article  Google Scholar 

  45. Melamed ML, Michos ED, Post W, Astor B (2008) 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168(15):1629–1637. doi:10.1001/archinte.168.15.1629

    Article  Google Scholar 

  46. Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr (2009) Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 57(9):1595–1603. doi:10.1111/j.1532-5415.2009.02359.x

    Article  Google Scholar 

  47. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI (2010) Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988–2006). Cancer Res 70(21):8587–8597. doi:10.1158/0008-5472.CAN-10-1420

    Article  CAS  Google Scholar 

  48. Ragavan VV, Smith JE, Bilezikian JP (1982) Vitamin A toxicity and hypercalcemia. Am J Med Sci 283(3):161–164

    Article  CAS  Google Scholar 

  49. Weinstein SJ, Yu K, Horst RL, Parisi D, Virtamo J, Albanes D (2011) Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study. PLoS One 6(6):e20796. doi:10.1371/journal.pone.0020796

    Article  CAS  Google Scholar 

  50. Cheng TY, Goodman GE, Thornquist MD, Barnett MJ, Beresford SA, Lacroix AZ, Zheng Y, Neuhouser ML (2014) Estimated intake of vitamin D and its interaction with vitamin A on lung cancer risk among smokers. Int J Cancer. doi:10.1002/ijc.28846

    Google Scholar 

  51. Bates CJ, Hamer M, Mishra GD (2012) A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: the National Diet and Nutrition Survey of People Aged 65 Years and Over. Osteopor Int 23(2):457–466. doi:10.1007/s00198-011-1543-z

    Article  CAS  Google Scholar 

  52. Kestenbaum B, Katz R, de Boer I, Hoofnagle A, Sarnak MJ, Shlipak MG, Jenny NS, Siscovick DS (2011) Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 58(14):1433–1441. doi:10.1016/j.jacc.2011.03.069

    Article  CAS  Google Scholar 

  53. Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R (2010) Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur J Endocrinol 162(5):935–942. doi:10.1530/EJE-09-1041

    Article  CAS  Google Scholar 

  54. Rohrmann S, Braun J, Bopp M, Faeh D, Swiss National C (2013) Inverse association between circulating vitamin D and mortality-dependent on sex and cause of death? Nutr Metab Cardiovasc Dis 23(10):960–966. doi:10.1016/j.numecd.2013.05.005

    Article  CAS  Google Scholar 

  55. Zou A, Elgort MG, Allegretto EA (1997) Retinoid X receptor (RXR) ligands activate the human 25-hydroxyvitamin D3-24-hydroxylase promoter via RXR heterodimer binding to two vitamin D-responsive elements and elicit additive effects with 1,25-dihydroxyvitamin D3. J Biol Chem 272(30):19027–19034

    Article  CAS  Google Scholar 

  56. Arnhold T, Tzimas G, Wittfoht W, Plonait S, Nau H (1996) Identification of 9-cis-retinoic acid, 9,13-di-cis-retinoic acid, and 14-hydroxy-4,14-retro-retinol in human plasma after liver consumption. Life Sci 59(12):PL169–PL177

    Article  CAS  Google Scholar 

  57. Millen AE, Dodd KW, Subar AF (2004) Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 104(6):942–950. doi:10.1016/j.jada.2004.03.022

    Article  Google Scholar 

  58. Bailey RL, Gahche JJ, Lentino CV, Dwyer JT, Engel JS, Thomas PR, Betz JM, Sempos CT, Picciano MF (2011) Dietary supplement use in the United States, 2003–2006. J Nutr 141(2):261–266. doi:10.3945/jn.110.133025

    Article  CAS  Google Scholar 

  59. Park YK, Kim I, Yetley EA (1991) Characteristics of vitamin and mineral supplement products in the United States. Am J Clin Nutr 54(4):750–759

    CAS  Google Scholar 

Download references

Acknowledgments

We thank Aline Richard for her help in initial stages of statistical analysis.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Laboratory of Human Nutrition, Institute of Food, Nutrition and Health, ETH Zurich, Zurich, Switzerland

    Einat Avital Schmutz & Michael Bruce Zimmermann

  2. Department of Chronic Disease Epidemiology, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland

    Sabine Rohrmann

Authors
  1. Einat Avital Schmutz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Bruce Zimmermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sabine Rohrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sabine Rohrmann.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 37 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schmutz, E.A., Zimmermann, M.B. & Rohrmann, S. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements. Eur J Nutr 55, 393–402 (2016). https://doi.org/10.1007/s00394-015-0860-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-015-0860-y

Keywords

Search

Navigation